Iprêt (Standaard)

Iproniazid (Standard) is the analytical standard of Iproniazid. This product is intended for research and analytical applications. Iproniazid is an orally active, irreversible, non-selective monoamine oxidase (MAO) inhibitor. Iproniazid inhibits MAO activity and enhances Rotenone (HY-B1756) -induced Apoptosis. Iproniazid modulates neurotransmitter levels, affects neuronal function, induces hepatic necrosis, and interferes with the endocrine system. Iproniazid can be used in the research of depression, Parkinson's disease, and hepatotoxicity[1][2][3][4][5][6][7].

54-92-2

12352100

Apoptosis; Monoamine Oxidase; Reference Standards

Apoptosis; Neuronal Signaling; Others

Endocrinology; Metabolic Disease; Neurological Disease

O=C(C1=CC=NC=C1)NNC(C)C

C9H13N3O

179.22

[1]Fagervall I, et al. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors. Biochemical pharmacology 35 (8) : 1381–1387

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-B0886AR/

Reference Standards